XBIT · NASDAQ
XBiotech (XBIT) Stock Price & Fundamentals
XBiotech (XBIT) closed at $278.51 on Oct 9, 2026, up 1.62% from the previous close of $274.07.
Share price, past year
1Y +29.62%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $278.51 |
| Sep 30, 2026 | $276.28 |
| Aug 31, 2026 | $281.03 |
| Jul 31, 2026 | $262.52 |
| Jun 30, 2026 | $254.36 |
| May 29, 2026 | $241.86 |
| Apr 30, 2026 | $241.80 |
| Mar 31, 2026 | $226.42 |
| Feb 27, 2026 | $224.62 |
| Jan 30, 2026 | $219.48 |
| Dec 31, 2025 | $222.33 |
| Nov 28, 2025 | $226.96 |
| Oct 31, 2025 | $225.59 |
Key statistics
- Market cap
- $8.49B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- −$45.13M
- Shares outstanding
- 30.5M
- Dividend yield
- —
- 52-week range
- $213.64 – $283.64
XBiotech's market cap is $8.49B, based on a share price of $278.51 and 30.5M shares outstanding as of Jun 30, 2026.
Financials
XBiotech reported revenue of $0.00 for fiscal 2023, down 100.00% from fiscal 2022.
XBiotech reported a net loss of $45.54M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2023ended Dec 31, 2023 | $0.00 | −100.0% | −$24.56M | — | −$0.81 | −$19.09M |
| FY2022ended Dec 31, 2022 | $4.01M | −78.2% | −$32.90M | −820.5% | −$1.08 | −$15.41M |
| FY2021ended Dec 31, 2021 | $18.39M | −58.2% | −$17.41M | −94.7% | −$0.58 | $65.92M |
| FY2020ended Dec 31, 2020 | $44.00M | — | −$11.22M | −25.5% | −$0.36 | −$68.88M |
| FY2019ended Dec 31, 2019 | $0.00 | — | $668.63M | — | $14.44 | −$18.47M |
| FY2018ended Dec 31, 2018 | $0.00 | — | −$21.14M | — | −$0.59 | −$16.66M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q4 FY2023ended Dec 31, 2023 | $0.00 | — | — |
| Q3 FY2023ended Sep 30, 2023 | $0.00 | — | — |
| Q2 FY2023ended Jun 30, 2023 | $0.00 | — | — |
| Q1 FY2023ended Mar 31, 2023 | $0.00 | — | — |
| Q4 FY2022ended Dec 31, 2022 | $300.00K | — | — |
| Q3 FY2022ended Sep 30, 2022 | $1.68M | — | — |
| Q2 FY2022ended Jun 30, 2022 | $1.53M | — | — |
| Q1 FY2022ended Mar 31, 2022 | $500.00K | — | — |
Company profile
- Name
- XBiotech Inc.
- Ticker
- XBIT
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 5217 Winnebago Lane, Austin, TX 78744
- Incorporated in
- A1
- Fiscal year ends
- December
- SEC CIK
- 0001626878
Recent SEC filings
- Aug 13, 2026
- May 14, 2026
- Apr 29, 2026
- Mar 13, 2026
- Dec 9, 2025
- Nov 12, 2025
- Oct 3, 2025
- Sep 2, 2025
Frequently asked questions
What is XBiotech's stock price?
XBiotech (XBIT) closed at $278.51 on Oct 9, 2026, up 1.62% from the previous close of $274.07.
What is XBiotech's market cap?
XBiotech's market cap is $8.49B, based on a share price of $278.51 and 30.5M shares outstanding as of Jun 30, 2026.
How much revenue does XBiotech make?
XBiotech reported revenue of $0.00 for fiscal 2023, down 100.00% from fiscal 2022.
Does XBiotech pay a dividend?
XBiotech's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from XBiotech Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures